BTA biota holdings limited

What did we get?, page-8

  1. 933 Posts.
    lightbulb Created with Sketch. 148
    DS sold 20 million yens worth of Inavir.

    If ever a good compound was screwed up by a pharmaceutical company, this was it. First, letting tamiflu beat relenza in the US, then letting inavir die in fully funded but poorly designed and poorly executed US trials. Why? Because they sold the company cheap and brought in poor managers.

    DS saw the potential in the compound so early. Biota were just stupid.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.